AU564667B2 - 5 (or 3- amino-6-)substituted phenyl)-2, 3 or (2,5)- dihydro-3 (or5)-imoni-2 alkyl 1, 2, 4 triazine - Google Patents

5 (or 3- amino-6-)substituted phenyl)-2, 3 or (2,5)- dihydro-3 (or5)-imoni-2 alkyl 1, 2, 4 triazine

Info

Publication number
AU564667B2
AU564667B2 AU34758/84A AU3475884A AU564667B2 AU 564667 B2 AU564667 B2 AU 564667B2 AU 34758/84 A AU34758/84 A AU 34758/84A AU 3475884 A AU3475884 A AU 3475884A AU 564667 B2 AU564667 B2 AU 564667B2
Authority
AU
Australia
Prior art keywords
imoni
triazine
dihydro
amino
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU34758/84A
Other languages
English (en)
Other versions
AU3475884A (en
Inventor
Geoffrey Allan
Alistair Ainslie Miller
David Alan Sawyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU3475884A publication Critical patent/AU3475884A/en
Application granted granted Critical
Publication of AU564667B2 publication Critical patent/AU564667B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU34758/84A 1983-10-27 1984-10-26 5 (or 3- amino-6-)substituted phenyl)-2, 3 or (2,5)- dihydro-3 (or5)-imoni-2 alkyl 1, 2, 4 triazine Ceased AU564667B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838328757A GB8328757D0 (en) 1983-10-27 1983-10-27 Chemical compounds
GB8328757 1983-10-27

Publications (2)

Publication Number Publication Date
AU3475884A AU3475884A (en) 1985-05-09
AU564667B2 true AU564667B2 (en) 1987-08-20

Family

ID=10550834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34758/84A Ceased AU564667B2 (en) 1983-10-27 1984-10-26 5 (or 3- amino-6-)substituted phenyl)-2, 3 or (2,5)- dihydro-3 (or5)-imoni-2 alkyl 1, 2, 4 triazine

Country Status (21)

Country Link
US (1) US4649139A (ru)
EP (1) EP0142306A3 (ru)
JP (1) JPS60109577A (ru)
KR (1) KR890000991B1 (ru)
AU (1) AU564667B2 (ru)
CA (1) CA1261328A (ru)
DD (1) DD224033A5 (ru)
DK (1) DK512184A (ru)
ES (1) ES8606304A1 (ru)
FI (1) FI844212L (ru)
GB (1) GB8328757D0 (ru)
GR (1) GR80723B (ru)
HU (1) HU191566B (ru)
IL (1) IL73332A (ru)
MC (1) MC1628A1 (ru)
NZ (1) NZ210000A (ru)
PH (1) PH21926A (ru)
PL (1) PL144899B1 (ru)
PT (1) PT79416B (ru)
SU (1) SU1371500A3 (ru)
ZA (1) ZA848388B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9218113D0 (en) * 1992-08-26 1992-10-14 Lilly Industries Ltd Pharmaceutical compounds
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
AU763244B2 (en) * 2000-01-03 2003-07-17 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
IL134730A (en) * 2000-02-25 2003-10-31 Chemagis Ltd Process for preparing substituted benzoyl cyanide amidinohydrazones
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
GB0613836D0 (en) * 2006-07-13 2006-08-23 Univ Greenwich New medical use of triazine derivatives
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
GB0800741D0 (en) * 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
GB2471713A (en) * 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
GB2471729A (en) 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2016198878A1 (en) 2015-06-12 2016-12-15 University Of Greenwich Triazine derivatives as interferon-gamma inhibitors
CN109810070B (zh) * 2019-01-29 2022-03-15 太原理工大学 一种含有双酰氧基结构的三嗪酮衍生物及其制备方法和应用
GB202006080D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Cytokine storm syndrome
GB202006076D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Interleukin inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759014A (en) * 1952-02-26 1956-10-10 Wellcome Found Improvements in triazines and their manufacture
BG15760A3 (bg) * 1968-06-29 1976-06-21 Неизвестен Метод за получаване на производни на 5-имино- 1, 2, 4- триазина
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DE2003144C3 (de) * 1970-01-24 1980-01-10 Bayer Ag, 5090 Leverkusen 5-Imino-6-alkyl-1^2,4-triazin-Derivate und Verfahren zu deren Herstellung
EP0021120B1 (en) * 1979-06-01 1983-04-06 The Wellcome Foundation Limited 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
CS234018B2 (en) * 1979-06-01 1985-03-14 Wellcome Found Method of 3,5-diammino-6-1,2,4-triazine derivatives making
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
SU1371500A3 (ru) 1988-01-30
KR890000991B1 (ko) 1989-04-15
EP0142306A2 (en) 1985-05-22
GR80723B (en) 1985-02-07
PH21926A (en) 1988-04-08
IL73332A (en) 1988-06-30
HUT36102A (en) 1985-08-28
PL250213A1 (en) 1985-12-03
HU191566B (en) 1987-03-30
ZA848388B (en) 1986-06-25
ES537104A0 (es) 1986-04-16
GB8328757D0 (en) 1983-11-30
CA1261328A (en) 1989-09-26
NZ210000A (en) 1987-08-31
DD224033A5 (de) 1985-06-26
IL73332A0 (en) 1985-01-31
PL144899B1 (en) 1988-07-30
PT79416A (en) 1984-11-01
DK512184A (da) 1985-04-28
FI844212A0 (fi) 1984-10-26
ES8606304A1 (es) 1986-04-16
KR850002964A (ko) 1985-05-28
DK512184D0 (da) 1984-10-26
JPS60109577A (ja) 1985-06-15
MC1628A1 (fr) 1985-09-26
PT79416B (en) 1986-11-13
AU3475884A (en) 1985-05-09
US4649139A (en) 1987-03-10
EP0142306A3 (en) 1986-11-20
FI844212L (fi) 1985-04-28

Similar Documents

Publication Publication Date Title
AU564667B2 (en) 5 (or 3- amino-6-)substituted phenyl)-2, 3 or (2,5)- dihydro-3 (or5)-imoni-2 alkyl 1, 2, 4 triazine
AU550035B2 (en) 3,5-di-tert-butyl-4-hydroxyphenyl substituted heterocyclic compound
AU565236B2 (en) 1,2-diaminocyclohexyl amide compounds
AU556084B2 (en) 4-(2-fluoro-4-halo-5-substituted phenyl)-urazols
CS672184A2 (en) Zpusob vyroby 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)alkyl)piperazinovych derivatu
KR870001234B1 (en) 2,6-substituted compound
AU564189B2 (en) 2 substituted phenyl 4, 5, 6, 7 tetrahydro-2h-isoindole- 13 diones
AU7719287A (en) 1-(substituted phenyl)-2-pyridones
AU547655B2 (en) Phenyl alkyl amine compounds, variously substituted
AU3250884A (en) Phenyl substituted pyridazinone
AU568997B2 (en) Substituted 5-(1,4-piperazinyl)-2,4-diaminopyridine
AU2580984A (en) Substituted 6,7-dihydro-benzo(i,j)quinolizines
AU567345B2 (en) 2, 4-dihydro-5-((substituted) phenyl)-4, 4-disubstituted- 3h-pyrazol-3-ones
AU566022B2 (en) 1,(2-aryl-2-halo-1-ethenyl)-1 h-azoles
AU549310B2 (en) N- 2-dihydroxyphosphinyl -3- substituted phenyl propionyl -leucine
AU7334487A (en) Phenyl substituted 1,2,4-triazole derivatives
AU540599B2 (en) Phenyl quinolizidines
GB2156354B (en) 1,23-dihydroxyvitamin d compounds
GB2127016B (en) 4-substituted phenyl 4'-(5-n-alkyl-1,3-dioxan-2-yl) thiobenzoates
AU572213B2 (en) Substituted 1,2,4-thiadiazines
ZM5984A1 (en) Substituted 2,6 substituted pyridine compounds
GB2163148B (en) Phenyl derivatives of 2,4-dimethyl-2-hexene
AU3311384A (en) Forfarande och anordning for kvantitativ matning av nh3 i ettprov
AU2480284A (en) Herbicidal alkoximinoalkylamino-1,3,5-triazines
ZA843322B (en) 2,4-dihydro-5-((substituted)phenyl)-4,4-disubstituted-3h-pyrazol-3-ones